Model Checkpoint Epoch: 5.0
Evaluation Model Used: gpt-5-mini
Number of Prompts Printed: 5
Number of Prompts Used for Calculating the Average for Each Metric: 20
QLoRA Adapter Configuration:
	Rank: 16
	QLoRA Alpha: 16.0 

================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Undernutrition in neonates increases the risk of serious morbidities. The objective of this study was to describe neonatal morbidity associated with low body fat percentage (BF%) and measure the number of undernourished neonates defined by BF% and compare this with birth weight percentiles (<10th). Eligibility included term (≥37 wk) neonates. BF% measurements were undertaken by air displacement plethysmography. Data on neonatal outcomes were extracted from medical records and used to develop a measure of neonatal morbidity. We assessed the association between neonatal morbidity and population-based birth weight percentiles compared with the BF% measurements. Five hundred and eighty-one neonates were included. Low BF% was defined by 1 SD below the mean and identified in 73 per 1,000 live births. Neonatal morbidity was found in 3.4% of neonates. Birth weight percentile was associated with neonatal morbidity (odds ratio (OR): 1.03 (95% confidence interval (CI): 1.01, 1.05); P =<0.001). BF% was associated with a higher risk of neonatal morbidity (OR: 1.30 (95% CI: 1.15, 1.47); P =<0.001).
Question:
Is body fat percentage a better measure of undernutrition in newborns than birth weight percentiles?
[/INST]

Generated Answer: The results suggest that BF% is a more sensitive measure of undernutrition than birth weight percentiles in neonates. The identification of low BF% in 73 per 1,000 live births suggests that there is an increased risk of neonatal morbidity with even relatively mild degrees of undernutrition. The use of BF% as a measure of undernutrition may be particularly useful for identifying at-risk neonates who would not have been detected using birth weight percentiles alone. This should help target interventions aimed at reducing the risk of serious morbidities in these infants. Further studies are required to confirm our findings.

Provided Answer: In this population, measuring BF% is more closely associated with identification of neonates at risk of neonatal morbidity as compared with birth weight percentiles. BF% measurements could assist with identifying neonates who are appropriately grown yet undernourished and exclude small neonates not at risk. 

correctness: 0.9
Reasoning:
The assistant's answer correctly interprets the study: body fat percentage (BF%) was more strongly associated with neonatal morbidity than birth weight percentiles and can identify at-risk infants who would be missed by birth weight alone. The response is accurate and appropriately cautious in recommending further study, though it could be improved by citing the reported effect sizes (e.g., OR for BF% 1.30 vs OR for birth weight percentile 1.03 and neonatal morbidity rate 3.4%) to quantify the difference.

conciseness: 0.8
Reasoning:
The assistant’s reply directly answers the question ("yes") and succinctly explains that BF% detects at-risk neonates missed by birth weight percentiles, matching the study's main conclusion. It is generally concise and on point, though it could be slightly tighter by omitting speculative language about interventions and by briefly citing the stronger association (e.g., the larger OR) to support the claim.

relevance: 0.9
Reasoning:
The assistant's reply is relevant and directly answers the question by stating that BF% is a better (more sensitive) measure than birth weight percentiles. It cites a real figure from the context (73 per 1,000 live births) and correctly conveys that BF% can identify at-risk neonates who would be missed by birth weight percentiles. Minor weaknesses: it does not mention the comparative effect sizes (ORs) reported in the study and makes a small extrapolation about targeting interventions without presenting supporting detail. Overall the response aligns well with the provided context.

coherence: 0.8
Reasoning:
The assistant's reply is clear, concise, and directly answers the question by stating that BF% appears more sensitive than birth weight percentiles for detecting undernutrition and at-risk neonates. The response is well organized (finding → implication → recommendation) and appropriately cautious by calling for further study. Minor weaknesses for maximal clarity include omission of the comparative effect sizes (ORs/confidence intervals) and the fact that birth weight percentiles were also associated with morbidity, albeit less strongly — including these would make the answer more informative but would not affect its coherence.

helpfulness: 0.7
Reasoning:
The assistant's reply correctly concludes that BF% appears to be a better indicator of undernutrition-related risk than birth weight percentiles and notes the practical advantage of detecting at-risk neonates missed by weight-based screening. It is concise and appropriately cautious in calling for further research. However, it omits key quantitative evidence from the study (sample size, morbidity rate, and the reported odds ratios and confidence intervals showing a stronger association for BF%), and it does not mention study scope/limitations (term neonates only, measurement method), which would help judge generalizability.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
We retrospectively collected and analyzed data of all diabetic patients affected by Charcot neuroarthropathy in combination with critical limb ischemia, which arrived to our care for the presence of foot lesions and underwent endovascular revascularization, followed by surgical and orthopedic treatment between January 2010 and January 2012. The primary end point was to assess the limb salvage rate. The secondary end point was to evaluate the healing time of the lesions. Ten diabetic patients (10 men; mean age 69.1±8.5 years), affected by ischemic Charcot neuroarthropathy underwent endovascular revascularization, surgical debridement and orthopedic correction. The limb salvage rate was 90%, avoiding major amputation in 9 patients. In one patient (10%) the infection could not be controlled and below-the-knee amputation was carried out. The required time to heal the lesion was in mean 197.4±22.4 days, after revascularization, surgical and orthopedic treatment.
Question:
Ischemic Charcot foot: different disease with different treatment?
[/INST]

Generated Answer: Our results indicate that Charcot neuroarthropathy associated with critical limb ischemia should be considered as a single disease entity, rather than two separate entities. The treatment of Charcot neuroarthropathy is similar to the treatment of critical limb ischemia, even if they have distinct pathophysiological mechanisms. We suggest that the term "ischemic Charcot foot" should be used instead of "diabetic Charcot neuropathy," to stress the role of arterial insufficiency in this condition. Further studies are needed to clarify the clinical relevance of these differences. Therefore, we propose a new classification system based on the pathogenesis of the disease. This system would allow us to better understand the natural history of Charcot neuroarthropathy and its evolution during treatment.

Provided Answer: Patients with Charcot foot deformity can be affected by critical limb ischemia and revascularization therapy is necessary, to support surgical and orthopedic treatment, avoiding amputation and leading to limb and foot salvage. 

correctness: 0.3
Reasoning:
The assistant's reply is misleading and omits key, evidence-supported points. The study's main clinical message is that ischemic Charcot foot requires revascularization in addition to surgical and orthopedic care to achieve high limb-salvage rates; the assistant instead claims the two conditions should be treated as a single disease entity, suggests renaming/classification changes without supporting data, and fails to emphasize the necessity and benefit of revascularization and the reported limb-salvage/healing outcomes. These statements are not justified by the presented data and could lead to inappropriate clinical interpretation.

conciseness: 0.5
Reasoning:
The assistant's reply is moderately concise but not fully to the point. It makes broad claims about treating ischemic Charcot as a single disease entity and proposes renaming/classifying it, yet it fails to state the key practical implication from the data — that revascularization is necessary to support surgical/orthopedic treatment and improve limb salvage — and includes speculative recommendations that go beyond the supplied results. Overall it answers the question only partially and adds unnecessary proposals.

relevance: 0.4
Reasoning:
The assistant's reply addresses the question by taking a position on whether ischemic Charcot foot is distinct, but it fails to ground that position in the actual study data from the context. It makes unwarranted general claims (e.g., that treatments are "similar" for Charcot neuroarthropathy and critical limb ischemia) without referencing the study's key findings — notably that endovascular revascularization followed by surgical/orthopedic treatment achieved a 90% limb-salvage rate and a mean healing time of ~197 days — and it introduces a proposal for a new classification without supporting evidence from the provided dataset. Because relevance here requires referring to real quotes or data from the context, the response is only partially relevant and omits important contextual evidence.

coherence: 0.5
Reasoning:
The assistant's reply is coherent and organized: it gives a clear position (treat ischemic Charcot foot as a single entity and favor the term "ischemic Charcot foot"), and it recommends further study and a classification change. However, it fails to engage with the provided data (no mention of revascularization, limb-salvage rates, healing times, or that revascularization is necessary to support surgical/orthopedic treatment), and it makes a strong diagnostic/terminology claim without evidence from the presented series. Overall the response is logically structured but incomplete and not well supported by the supplied findings.

helpfulness: 0.4
Reasoning:
The assistant's reply is poorly aligned with the presented data and the likely clinical conclusion. It makes a broad, unsupported claim that Charcot neuroarthropathy with critical limb ischemia should be treated as "a single disease entity" and that treatment is "similar to" critical limb ischemia, but it fails to report or use the study's key findings (the 90% limb-salvage rate after endovascular revascularization plus surgery/orthopedics, the mean healing time, or the statement that revascularization is necessary to support limb- and foot-salvage). The suggestion to adopt the term "ischemic Charcot foot" and to create a new classification is speculative and not justified by evidence or details in the response. The answer is therefore not sufficiently helpful or evidence-based: it is vague, omits important outcome data, and makes conclusions beyond what the presented data support.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Radical hysterectomy is recommended for endometrial adenocarcinoma patients with suspected gross cervical involvement. However, the efficacy of operative procedure has not been confirmed. The patients with endometrial adenocarcinoma who had suspected gross cervical involvement and underwent hysterectomy between 1995 and 2009 at seven institutions were retrospectively analysed (Gynecologic Oncology Trial and Investigation Consortium of North Kanto: GOTIC-005). Primary endpoint was overall survival, and secondary endpoints were progression-free survival and adverse effects. A total of 300 patients who underwent primary surgery were identified: 74 cases with radical hysterectomy (RH), 112 patients with modified radical hysterectomy (mRH), and 114 cases with simple hysterectomy (SH). Median age was 47 years, and median duration of follow-up was 47 months. There were no significant differences of age, performance status, body mass index, stage distribution, and adjuvant therapy among three groups. Multi-regression analysis revealed that age, grade, peritoneal cytology status, and lymph node involvement were identified as prognostic factors for OS; however, type of hysterectomy was not selected as independent prognostic factor for local recurrence-free survival, PFS, and OS. Additionally, patients treated with RH had longer operative time, higher rates of blood transfusion and severe urinary tract dysfunction.
Question:
Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?
[/INST]

Generated Answer: The results suggest that there is no evidence to support that radical hysterectomy provides additional benefits for patients with endometrial cancer suspected cervical involvement. It may be unnecessary in such cases. The surgical approach should be carefully considered by physicians based on patient characteristics, clinical staging, and postoperative outcomes. Future studies will further determine whether less extensive procedures are sufficient for these patients. Radical hysterectomy might be associated with increased morbidity. Therefore, it is important to consider individualized treatment strategies according to the patient's condition. In addition, it would be beneficial to conduct prospective trials to evaluate the role of radical hysterectomy in this population.

Provided Answer: Type of hysterectomy was not identified as a prognostic factor in endometrial cancer patients with suspected gross cervical involvement. Perioperative and late adverse events were more frequent in patients treated with RH. The present study could not find any survival benefit from RH for endometrial cancer patients with suspected gross cervical involvement. Surgical treatment in these patients should be further evaluated in prospective clinical studies. 

correctness: 0.9
Reasoning:
The assistant's answer correctly and concisely reflects the study's main findings: radical hysterectomy (RH) did not show survival benefit for endometrial cancer with suspected gross cervical involvement and was associated with greater morbidity, and the conclusion that surgical strategy should be individualized and evaluated in prospective trials matches the authors' recommendations. The response could be improved by briefly noting that type of hysterectomy was not an independent prognostic factor on multivariable analysis and by giving specific examples of increased harms (longer operative time, higher transfusion rates, more urinary dysfunction), but these are omissions of detail rather than inaccuracies.

conciseness: 0.8
Reasoning:
The assistant's reply is direct and stays on point: it states the main conclusion (no evidence that radical hysterectomy adds benefit), notes increased morbidity with RH, and recommends individualized treatment and prospective trials. It is concise, but a bit repetitive and could be slightly tighter or include the key study specifics (that type of hysterectomy was not an independent prognostic factor and RH had higher perioperative/late adverse events).

relevance: 0.8
Reasoning:
The assistant's reply is relevant and generally accurate: it conveys the study's main conclusions that radical hysterectomy showed no survival benefit and was associated with greater morbidity, and it appropriately recommends individualized treatment and prospective trials. It paraphrases the trial findings rather than quoting specific lines or reporting numerical details (sample sizes, exact endpoints, or which factors were prognostic), so it is somewhat non-specific.

coherence: 0.8
Reasoning:
The response is coherent and well organized: it succinctly summarizes the study conclusion that radical hysterectomy offers no clear survival benefit for endometrial cancer with suspected gross cervical involvement and notes the increased morbidity and need for individualized decision-making and prospective trials. It is concise and directly answers the question. Minor weaknesses are that it is somewhat generic and omits specific study details (sample size, quantified adverse-event findings, and that hysterectomy type was not an independent prognostic factor), which would strengthen the summary.

helpfulness: 0.8
Reasoning:
The assistant's reply is a concise and accurate summary of the study's main conclusions: radical hysterectomy showed no clear survival benefit for endometrial cancer with suspected gross cervical involvement and was associated with greater morbidity, so treatment should be individualized and prospective trials are warranted. It is helpful and appropriately cautious. Shortcomings: it omits specific study details (sample size, follow-up, which prognostic factors were identified) and lacks mention that hysterectomy type was not an independent prognostic factor on multivariable analysis, which are relevant for readers evaluating the evidence strength.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
The morbidity and mortality of pancreaticoduodenectomy (PD) have significantly decreased over the past decades to the point that they are no longer the sole indicators of quality and safety. In recent times, hospital readmission is increasingly used as a quality metric for surgical performance and has direct implications on health-care costs. We sought to delineate the natural history and predictive factors of readmissions after PD. The clinicopathologic and long-term follow-up data of 1,173 consecutive patients who underwent PD between August 2002 and August 2012 at the Massachusetts General Hospital were reviewed. The NSQIP database was linked with our clinical database to supplement perioperative data. Readmissions unrelated to the index admission were omitted. We identified 173 (15 %) patients who required readmission after PD within the study period. The readmission rate was higher in the second half of the decade when compared to the first half (18.6 vs 12.3 %, p = 0.003), despite a stable 7-day median length of stay. Readmitted patients were analyzed against those without readmissions after PD. The demographics and tumor pathology of both groups did not differ significantly. In the multivariate logistic regression analysis, pancreatic fistula (18.5 vs 11.3 %, OR 1.86, p = 0.004), multivisceral resection at time of PD (3.5 vs 0.6 %, OR 4.02, p = 0.02), length of initial hospital stay>7 days (59.5 vs 42.5 %, OR 1.57, p = 0.01), and ICU admissions (11.6 vs 3.4 %, OR 2.90, p = 0.0005) were independently associated with readmissions. There were no postoperative biochemical variables that were predictive of readmissions. Fifty percent (n = 87) of the readmissions occurred within 7 days from initial operative discharge. The reasons for immediate (≤7 days) and nonimmediate (>7 days) readmissions differed; ileus, delayed gastric emptying, and pneumonia were more common in early readmissions, whereas wound infection, failure to thrive, and intra-abdominal hemorrhage were associated with late readmissions. The incidences of readmissions due to pancreatic fistulas and intra-abdominal abscesses were equally distributed between both time frames. The frequency of readmission after PD is 15 % and has been on the uptrend over the last decade.
Question:
Understanding hospital readmissions after pancreaticoduodenectomy: can we prevent them?
[/INST]

Generated Answer: This study highlights the need for careful patient selection, proper perioperative management, and aggressive postoperative care to reduce the likelihood of readmissions after PD. Prevention strategies include close monitoring of patients' postoperative course, prompt treatment of complications, and optimization of nutritional support. Further studies should be conducted to identify specific risk factors and develop evidence-based guidelines to improve outcomes and reduce costs. The development of an institutional protocol to optimize postoperative care may help to decrease readmission rates. In addition, further studies are needed to assess the impact of PD on readmission rates and the cost-effectiveness of various strategies aimed at reducing readmission rates. Further prospective studies are needed to evaluate the efficacy of these strategies.

Provided Answer: The complexity of initial resection and pancreatic fistula were independently associated with hospital readmissions after PD. Further efforts should be centered on preventing early readmissions, which constitute half of all readmissions. 

correctness: 0.3
Reasoning:
The assistant's reply is generic and offers reasonable high-level prevention ideas (closer monitoring, prompt complication treatment, nutritional support, institutional protocols). However it fails to reflect the study's core, evidence-based findings: it does not identify pancreatic fistula and complexity of the initial resection (multivisceral resection) as independent predictors of readmission, nor does it note that half of readmissions occur within 7 days and that efforts should especially target early readmissions. The response is repetitive about needing more studies and gives no concrete, study-linked recommendations based on the reported predictors. Overall it is not sufficiently specific or accurate relative to the presented data.

conciseness: 0.3
Reasoning:
Explanation: The reply is brief but overly generic and repetitive (multiple calls for "further studies") and fails to state the study's key, actionable findings — notably that pancreatic fistula and more complex/multivisceral resections independently predict readmission and that half of readmissions occur within 7 days (suggesting focus on preventing early readmissions). As written it is not sufficiently specific or targeted to the study results and thus is not fully to the point.

relevance: 0.2
Reasoning:
Explanation: The assistant's reply gives generic prevention strategies (closer monitoring, perioperative care, nutrition, institutional protocols) but does not refer to specific findings from the provided context. It fails to mention the study's key, quoted associations (pancreatic fistula and complexity/multivisceral resection being independently linked to readmission) or the important point that half of readmissions occur within 7 days and should be a target for prevention. Because it does not cite or draw on those real contextual results, its relevance to the question as framed by the study is limited.

coherence: 0.3
Reasoning:
The response is coherent and organized but overly generic and repetitive. It suggests reasonable general strategies (close monitoring, prompt treatment, nutritional optimization, institutional protocols) but fails to reference the study's key findings (pancreatic fistula and complex/multivisceral resections as independent predictors, or that half of readmissions occur within 7 days) or to prioritize preventing early readmissions. It also repeats calls for "further studies" without proposing specific, evidence-aligned interventions targeting the identified risk factors.

helpfulness: 0.4
Reasoning:
The assistant's reply is generic and offers plausible broad strategies (close monitoring, treating complications, nutritional optimization, institutional protocols) but it fails to engage with the study's key findings or to give targeted, evidence-linked recommendations. It does not mention the specific independent predictors identified (pancreatic fistula, multivisceral/complex resections, prolonged initial stay, ICU admission), nor does it highlight that half of readmissions occur within 7 days — a central point that implies prevention efforts should prioritize the immediate postdischarge period. The answer is also repetitive in calling for “further studies” without proposing concrete next steps or interventions based on the data.

Strengths:
- Suggests reasonable general prevention strategies and use of institutional protocols.

Weaknesses:
- Omits study-specific risk factors and their implications.
- Does not emphasize early readmissions (≈50% within 7 days) or propose specific early-postdischarge measures (e.g., early follow-up, targeted surveillance for pancreatic fistula).
- Largely nonactionable and repetitive.

================================================================================
Average correctness Score: 0.545
Average conciseness Score: 0.59
Average relevance Score: 0.565
Average coherence Score: 0.595
Average helpfulness Score: 0.535
